Gragnano, F.; Capolongo, A.; Terracciano, F.; Gargiulo, G.; De Sio, V.; Cesaro, A.; Moscarella, E.; Patti, G.; Porto, I.; Esposito, G.;
et al. Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice. J. Clin. Med. 2022, 11, 6246.
https://doi.org/10.3390/jcm11216246
AMA Style
Gragnano F, Capolongo A, Terracciano F, Gargiulo G, De Sio V, Cesaro A, Moscarella E, Patti G, Porto I, Esposito G,
et al. Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice. Journal of Clinical Medicine. 2022; 11(21):6246.
https://doi.org/10.3390/jcm11216246
Chicago/Turabian Style
Gragnano, Felice, Antonio Capolongo, Fabrizia Terracciano, Giuseppe Gargiulo, Vincenzo De Sio, Arturo Cesaro, Elisabetta Moscarella, Giuseppe Patti, Italo Porto, Giovanni Esposito,
and et al. 2022. "Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice" Journal of Clinical Medicine 11, no. 21: 6246.
https://doi.org/10.3390/jcm11216246
APA Style
Gragnano, F., Capolongo, A., Terracciano, F., Gargiulo, G., De Sio, V., Cesaro, A., Moscarella, E., Patti, G., Porto, I., Esposito, G., Angiolillo, D. J., & Calabrò, P.
(2022). Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice. Journal of Clinical Medicine, 11(21), 6246.
https://doi.org/10.3390/jcm11216246
